Amdocs Logs 4Q Sales Dip, Sees Revenue Growth in FY26

Dow Jones
Nov 12, 2025

By Elias Schisgall

 

Amdocs reported a decline in sales for its fiscal fourth quarter after winding down from some non-core business activities, but forecast a return to revenue growth over the next year.

The St. Louis, Missouri-based digital services provider posted a profit of $96.3 million, or 88 cents a share, compared with a profit of $86.4 million, or 76 cents a share, one year earlier.

Adjusted earnings were $1.83 cents a share. Analysts polled by FactSet expected $1.82.

Total revenue was $1.15 billion, down from $1.26 billion a year earlier. Analysts expected $1.15 billion. The 9% decrease in revenue was caused by a phase out of certain business activities, the company said. Amdocs said revenue was up 2.8% when adjusting for the end of certain low margin, non-core business activities and for currency translation.

Amdocs said it expects first-quarter revenue to be between $1.14 billion and $1.18 billion, and forecasted adjusted earnings per share of between $1.73 and $1.79.

Analysts were looking for revenue of $1.15 billion and adjusted earnings of $1.87 a share in the current quarter.

For its current fiscal year, Amdocs anticipates revenue growth between 1.7% and 5.7%. Revenue fell for fiscal 2025 fell to $4.53 billion from about $5 billion in 2024.

The company also projects per-share earnings will rise between 13.5% and 20% and between 4% and 8% on an adjusted basis in the fiscal year.

 

Write to Elias Schisgall at elias.schisgall@wsj.com

 

(END) Dow Jones Newswires

November 11, 2025 17:51 ET (22:51 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10